Cargando…
Generation of an in vitro model for peripheral neuropathy in Fabry disease using CRISPR-Cas9 in the nociceptive dorsal root ganglion cell line 50B11
Fabry disease is a glycosphingolipid storage disorder that is caused by a genetic deficiency of the lysosomal enzyme alpha-galactosidase A (AGA, EC 3.2.1.22). As a result, the glycolipid substrate, globotriaosylceramide (Gb3) accumulates in various cell types throughout the body producing a multisys...
Autores principales: | Kaneski, Christine R., Hanover, John A., Schueler Hoffman, Ulrike H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9248215/ https://www.ncbi.nlm.nih.gov/pubmed/35782611 http://dx.doi.org/10.1016/j.ymgmr.2022.100871 |
Ejemplares similares
-
Generation of GLA-knockout human embryonic stem cell lines to model peripheral neuropathy in Fabry disease
por: Kaneski, Christine R., et al.
Publicado: (2022) -
Shared nociceptive dorsal root ganglion neurons participating in acupoint sensitization
por: Li, Wanrong, et al.
Publicado: (2022) -
Cutaneous Aβ-Non-nociceptive, but Not C-Nociceptive, Dorsal Root Ganglion Neurons Exhibit Spontaneous Activity in the Streptozotocin Rat Model of Painful Diabetic Neuropathy in vivo
por: Djouhri, Laiche, et al.
Publicado: (2020) -
The mechanism of Annexin A1 to modulate TRPV1 and nociception in dorsal root ganglion neurons
por: Zhang, Yufen, et al.
Publicado: (2021) -
Erratum to “Differentiation of the 50B11 dorsal root ganglion cells into NGF and GDNF responsive nociceptor subtypes”
Publicado: (2020)